查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836737

眼科黏弹性手术器材市场（按产品类型、成分、应用、最终用户和分销管道）—2025-2032 年全球预测

Ophthalmic Viscosurgical Devices Market by Product Type, Composition, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，眼科黏液手术器械市场将成长至 14.1369 亿美元，复合年增长率为 9.12%。

主要市场统计数据
基准年2024年 7.0286亿美元
预计2025年 7.6593亿美元
预测年份：2032年 14.1369亿美元
复合年增长率（%） 9.12%

眼科黏液外科设备的综合说明，概述了它们的临床重要性、不断变化的手术实践压力和采购需求。

本执行摘要说明眼科黏弹手术器械 (OVD) 及其在现代前后段手术中的重要角色。本摘要旨在帮助临床领导者、采购负责人和产品负责人全面、均衡地理解影响手术中心和医院系统决策的临床驱动因素、产品创新、监管动态和分销变化。

OVD 是白内障、角膜、青光眼和玻璃体视网膜手术中不可或缺的辅助器具，在保护眼部组织的同时，也能实现可视化和便利操作。随着手术技术不断朝着更小切口和更快吞吐的方向发展，人们对 OVD 的性能、操作特性和供应可靠性的期望也日益提高。本介绍概述了以下章节中使用的假设，重点关注临床效用、供应商行为、监管影响和最终用户采购优先顺序。此外，本介绍也为更深入的洞察奠定了基础，包括变革趋势、关税影响、细分市场细微差别、区域差异以及产业相关人员应考虑的策略行动。

对推动眼科黏弹性手术器材价值链快速变化的临床、技术、监管和商业性力量的综合看法

过去几年，在临床、技术和商业力量融合的推动下，OVD 领域发生了重大变化。临床上，微切口白内障手术和高端人工水晶体的普及推动了对能够最大程度减少残留碎片、优化人工水晶体位置并维持前房稳定性的 OVD 的需求。同时，越来越多的手术在门诊进行，这推动了对易于操作且即使在高流量条件下也能保持稳定性能的产品的需求。这种临床发展与产品创新密切相关，配方的进步带来了黏度适应性和混合性配方，旨在提供腔体维护和内皮保护的双重益处，同时简化抽吸过程中的移除。

在监管和品质方面，对无菌保证、供应链可追溯性和器械分类的严格审查，迫使製造商投资加强其品质体系，在某些情况下，甚至重新设计包装和标籤，以符合新的区域要求。策略伙伴关係和选择性垂直整合正被用于稳定原料采购并提高生产弹性，尤其是在高纯度透明质酸钠领域。数位通路和供应商直销模式持续扩展，改变了与传统经销商的关係，并提供了更精细的使用模式数据。总而言之，这些转变正在加速产品组合合理化，推动对差异化製剂和给药系统的投资，并提升临床、监管和商业团队之间跨职能协作的重要性。

对 2025 年美国关税将如何调整供应链、转移采购并奖励本地製造业投资进行严格评估

2025年美国关税的累积效应可能会波及整个供应链，导致进口经销商和OVD成品到岸成本上升。那些在固定报销计划和受限采购预算下运营的工厂可能会面临额外的压力，迫使它们与供应商进行更严格的谈判，强调总体拥有成本，并儘可能转向国内替代方案。虽然拥有本地生产能力的大型综合製造商能够凭藉其规模优势吸收或减轻关税的影响，但依赖跨境零件采购的小型供应商可能面临更严重的利润率压缩。

医院和门诊中心的筹资策略可能会进行调整，包括延长合约週期、更多地使用框架协议来锁定价格，或更多地依赖集团采购组织来聚集需求，从而获得更优惠的条款。同时，经销商可能会调整库存策略，增加安全库存或重新平衡地域库存池，以对冲关税波动并维持服务水准。在创新方面，关税压力会奖励优化配方，提高原料的成本效益，并在法律允许的情况下重新设计包装，以减少进口关税分类。从中期来看，政策主导的贸易壁垒可能会加速区域製造业投资和供应商多元化，因为企业寻求保护净利率并保持高产量手术环境下的供应可靠性。总而言之，当经济和监管条件证明资本投资合理时，关税可以成为供应链重组、采购优化和选择性在岸外包的催化剂。

将产品配方、成分科学、临床应用、最终用户需求和分销管道经济与策略重点连结起来的详细細項分析

透过多种分析视角，可以更好地理解细分市场的性能和产品策略，这些视角可以阐明临床适用性、商业性潜力和营运要求。依产品类型分析可区分黏性、复合性、分散性和黏性适应性配方。黏性配方通常优先考虑腔体的维护和移除便利性；分散性配方强调在复杂手术过程中对内皮的保护和保留；复合配方则寻求这些属性之间的平衡；粘性适应性配方则根据不断变化的剪切条件调整其特性。基于成分的细分突出了复合物、羟丙基甲基纤维素和透明质酸钠在决定黏弹性行为、使用者偏好和成分依赖性方面的作用。透明质酸钠因其黏弹性稳定性，在许多先进配方中仍然是首选，而羟丙基甲基纤维素则具有在特定手术工作流程中备受重视的物料输送特性。

白内障手术、角膜手术、青光眼手术和玻璃体视网膜手术中的不同应用决定了不同的临床需求。白内障手术需要能够实现可预测囊膜支撑和晶状体植入的晶状体植入装置 (OVD)，角膜手术优先考虑内皮保护，青光眼手术强调维持空间以便进行基于角度的操作，而玻璃体视网膜手术通常需要在后节入路过程中进行专门的操作。门诊手术中心优先考虑支援高通量和易用性的产品，医院通常需要更广泛的处方来处理复杂病例，而专科诊所可能需要与亚专科手术相适应的利基处方。对直销、分销合作伙伴和电商分销管道的分析揭示了截然不同的市场进入模式。直销可以提供客製化的临床支援和合约执行，分销合作伙伴有助于广泛的地理覆盖和库存管理，而电商通路则提供便利性和数据透明度，但需要强大的物流和监管合规机制。结合这些细分观点，可以对产品开发重点、临床教育计划以及与特定程序和客户需求一致的商业管道进行投资。

区域差异观点，识别全球不同的采购实务、法规要求和供应链考量因素

区域动态正在塑造产品偏好、监管途径和供应链设计，从而在关键区域之间形成差异化的竞争格局。在美洲，稳定的手术量、成熟的采购体係以及强大的门诊手术中心，催生了对各种体外诊断 (OVD) 製剂的需求，这些製剂注重操作的一致性和合规性。在这些市场中运作的製造商必须在快速服务交付与严格的品质监管之间取得平衡，通常优先考虑临床证据的生成和关键意见领袖 (KOL) 的参与，以支持产品的采用。

欧洲、中东和非洲市场环境复杂多样，报销架构多样，监管协调机制多样，区域供应链复杂，需要采取区域市场策略。该地区一些国家由于集中采购或医院集团采购而对价格敏感，而其他国家则受临床偏好和专家网络的强烈影响。为了应对这种多样性，製造商受益于适应性监管策略和有针对性的临床项目。亚太地区是高容量需求中心，其外科手术能力正在快速扩张，推动了国内製造能力的提升。该地区拥有蓬勃发展的门诊网络和大型三级医院，相关人员通常优先考虑具有成本效益的製剂和强大的供应连续性。在所有地区，跨境监管协调、出口限制和原材料采购考量在塑造製造布局和分销策略方面发挥关键作用。

策略竞争分析强调创新、供应连续性和附加价值服务如何重新定义 OVD 领域的领导和差异化

透明质酸（OVD）产业的竞争动态体现在传统製造商、专业製造商和采用差异化市场策略的新兴企业之间。领先的公司正在投资配方科学以扩大临床效用，同时改进包装和给药系统以改善操作并减少浪费。策略重点包括扩大直接临床参与度、确保高纯度透明质酸来源的原材料供应链，以及利用监管部门的批准来支持关键治疗用途的标籤扩展。

中小型公司通常透过专注于利基市场、具有成本竞争力的配方或针对特定地域的分销伙伴关係关係来增强其影响力。各公司也越来越多地寻求将临床培训项目与门诊中心和医院系统的批量采购相结合的合作模式。併购仍然是一种活跃的策略槓桿，用于获取专有配方、扩大製造能力和进入互补的分销网络。透过临床教育、上市后研究和基于价值的合约提供的差异化服务正成为竞争定位的核心，因为买家不仅期望产品性能，还期望可预测的供应和可验证的结果支持。智慧财产权管理和品质系统的成熟度仍然是竞争优势的关键决定因素，特别是对于那些寻求进入核准要求严格的受监管市场的公司。

一份可行的策略蓝图，建议配方投资、供应多样化、商业模式调整和监管准备以维持成长

产业领导者应考虑采取多管齐下的方法，解决临床差异化、供应弹性、商业性敏捷性和监管前瞻性等问题。首先，优先投资于具有明显临床优势的製剂科学，例如增强内皮保护、易于移除和优化黏弹性能，以打造具有竞争力的产品差异化，使外科医生能够在其标准工作流程中轻鬆采用。其次，透过策略协议和多元化的供应商基础加强原材料采购，以减少贸易中断带来的风险，并提高在成本和前置作业时间的谈判能力。

商业模式透过扩大与门诊手术中心和大型医院系统的直接交易来适应不断变化的采购环境，同时完善分销商关係以确保区域覆盖和库存应对力。提高数位化——从订购和库存视觉到上市后回馈——可以改善客户体验并提供可操作的使用数据。必须不断升级监管和品质体系，以满足新的区域要求并加速标籤扩展。主动与监管机构合作并投资强有力的临床证据将有助于进入市场。最后，制定关税和贸易政策波动的应急计划，结合灵活的库存策略、区域生产选择和成本工程，以在不影响临床表现的情况下保护净利率。这些建议为推动采用、保护供应和保持竞争力提供了可行的蓝图。

一种透明而严谨的研究途径，结合专家访谈、监管调查、临床文献综合和迭代三角测量，以确保可操作的发现

本摘要所依据的研究将结构化的一手资料研究与有针对性的二次分析和方法论三角检定结合，以确保研究的稳健性和有效性。一手资料是透过与眼科医生、门诊和医院采购负责人、监管专家以及高级公司主管进行深入访谈收集的，旨在提供有关临床优先事项、采购驱动因素和供应链挑战的背景观点。二次资料包括公开的监管文件、临床文献、设备註册和企业资料，这些信息被整合起来以检验临床声明、製造方法和分销模式。

采用数据和洞察三角检定来协调相关人员观点与已发表资讯之间的差异，并采用迭代检验循环来完善解释。调查方法密切关注影响製剂选择和使用模式的区域法律规范和程序趋势。对于必要的假设，透过后续访谈和情境分析进行明确检验，以评估对政策变化、采购变化和临床应用障碍的敏感性。整体方法强调资讯来源的透明度、严格的交叉检验以及临床和商业观点的整合，从而为决策者提供可操作的资讯。

简洁的综合强调了临床驱动因素、供应弹性以及应对眼科医疗设备不断发展变化所需的协作商业策略

最后，OVD 领域的特点是持续的临床相关性、加速的技术创新以及适应新手术工作流程和采购现实的商业性格局。能够可靠保护眼部组织、支援先进的眼内手术并能顺利融入高通量环境的配方将受到临床医生和采购相关人员的关注。同时，供应链的弹性和监管敏捷性已成为业务的关键优先事项，尤其是在贸易政策变化和原材料供应波动的背景下。

相关人员将产品开发与明确的临床效益结合，投资于可论证的临床证据，并追求灵活的商业模式，将最有可能获得长期价值。配方创新、区域监管差异以及不断发展的分销模式之间的相互作用，凸显了在研发、生产和客户互动方面製定协作策略的必要性。透过专注于临床差异化、供应连续性和快速的商业性执行，产业参与者能够抵御短期波动，同时建立可持续的竞争优势。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 在复杂的白内障手术中越来越多地采用先进的 OVD 正在改善患者的治疗效果
  • 药物释放型眼科黏弹手术装置整合用于术后标靶治疗
  • 预填充抛弃式黏弹性注射器的需求不断增加，可降低污染风险并缩短手术时间
  • 微切口白内障手术的扩展推动了低黏度OVD配方的创新
  • 保护角膜内皮并促进其恢復的生物可吸收黏弹性材料的开发
  • 设备製造商与研究机构之间的策略伙伴关係加速了OVD技术的进步
  • 新型黏弹性聚合物获得监管部门核准，可实现更安全、更有效的眼内手术
  • 随着人口老化的出现，新兴市场对专门的眼科黏液手术设备的需求正在增加。
  • 模拟泪膜的黏弹剂组合的出现，可改善眼科介入期间的润滑
  • 专注于为资源有限地区的高容量手术中心提供经济高效的 OVD 解决方案

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 眼科黏弹性手术器材市场（依产品类型）

  • 凝聚力
  • 组合
  • 去中心化
  • 黏度适应型

9. 眼科黏弹性手术器材市场（依成分）

  • 组合
  • 羟丙基甲基纤维素
  • 透明质酸钠

第十章眼科黏弹性手术器械市场（按应用）

  • 白内障手术
  • 角膜手术
  • 青光眼手术
  • 玻璃体视网膜手术

11. 眼科黏弹性手术器材市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 专科诊所

12. 眼科黏弹性手术器械市场（依分销管道）

  • 直销
  • 经销商合作伙伴
  • 电子商务

13. 眼科黏弹性手术器材市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章眼科黏弹性手术器材市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 眼科黏弹性手术器材市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Alcon Laboratories, Inc.
    • Johnson & Johnson
    • Bausch+Lomb Incorporated
    • Carl Zeiss Meditec AG
    • HOYA Surgical Optics, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Rayner Group
    • Nordic Pharma, Inc.
    • Bohus BioTech AB
    • BVI Medical, Inc. a
Product Code: MRR-036C5CF3B495

The Ophthalmic Viscosurgical Devices Market is projected to grow by USD 1,413.69 million at a CAGR of 9.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 702.86 million
Estimated Year [2025] USD 765.93 million
Forecast Year [2032] USD 1,413.69 million
CAGR (%) 9.12%

A comprehensive orientation to ophthalmic viscosurgical devices outlining clinical importance, evolving surgical practice pressures, and procurement imperatives

This executive summary provides a focused orientation to ophthalmic viscosurgical devices (OVDs) and their pivotal role in contemporary anterior and posterior segment surgery. The content is designed to equip clinical leaders, procurement executives, and product strategists with a balanced synthesis of clinical drivers, product innovation, regulatory dynamics, and distribution shift factors that collectively shape decision-making across surgical centers and hospital systems.

OVDs serve as indispensable adjuncts during cataract, corneal, glaucoma, and vitreoretinal procedures, protecting ocular tissues while enabling visualization and access. As surgical techniques continue to evolve toward smaller incisions and faster throughput, the expectations placed on OVD performance, handling characteristics, and supply reliability have intensified. This introduction outlines the framing assumptions used across subsequent sections, emphasizing clinical utility, supplier behavior, regulatory influences, and end-user procurement priorities. It sets the stage for deeper insights into transformative trends, tariff impacts, segmentation nuances, regional differentiation, and strategic actions that industry stakeholders should consider.

An integrated view of the clinical, technological, regulatory, and commercial forces driving rapid transformation across the ophthalmic viscosurgical devices value chain

Several transformative shifts have reshaped the OVD landscape in recent years, driven by converging clinical, technological, and commercial forces. Clinically, the widespread adoption of microincision cataract surgery and premium intraocular lenses has increased demand for OVDs that provide sustained anterior chamber stability while minimizing residue and optimizing intraocular lens positioning. Concurrently, surgical practice has migrated more procedures to ambulatory settings, creating a premium on products that combine ease of handling with consistent performance under high-turnover conditions. These clinical evolutions are tightly coupled with product innovation, where formulary advances are producing viscoadaptive and combination compositions intended to deliver dual benefits of space maintenance and endothelial protection, while enabling simplified removal during aspiration.

On the regulatory and quality front, heightened scrutiny over sterility assurance, supply chain traceability, and device classification has prompted manufacturers to invest in enhanced quality systems and in some cases to redesign packaging and labeling to align with new regional requirements. The supply chain itself is undergoing consolidation; strategic partnerships and selective vertical integration are being used to stabilize raw material sourcing-particularly for high-purity sodium hyaluronate-and to improve manufacturing resilience. Digital channels and direct-to-provider distribution models continue to expand, altering traditional distributor relationships and enabling more granular data capture on usage patterns. Taken together, these shifts are accelerating portfolio rationalization, encouraging investments in differentiated formulations and delivery systems, and elevating the importance of cross-functional collaboration between clinical, regulatory, and commercial teams.

A rigorous assessment of how 2025 tariff measures in the United States create supply chain recalibration, procurement shifts, and incentives for localized manufacturing investments

The cumulative effects of tariff measures implemented in the United States during 2025 introduce a new set of operational and strategic considerations for manufacturers, distributors, and healthcare providers. Tariff-induced cost pressures are likely to be transmitted through the supply chain, increasing landed costs for imported raw materials and finished OVD products. Facilities operating under fixed reimbursement schedules and constrained procurement budgets may experience added strain, prompting more rigorous supplier negotiations, greater emphasis on total cost of ownership, and potential shifts toward domestically produced alternatives where feasible. The operational response is not uniform; larger integrated manufacturers with localized production capabilities can absorb or mitigate some tariff impacts through scale, while smaller suppliers that rely on cross-border component sourcing may face more acute margin compression.

Procurement strategies at hospitals and ambulatory centers tend to adjust via longer contract cycles, expanded use of framework agreements that lock in prices, or heightened reliance on group purchasing organizations that aggregate demand to secure more favorable terms. In parallel, distributors may reconfigure inventory strategies to hedge against tariff volatility and to preserve service levels, increasing safety stock or rebalancing geographic inventory pools. On the innovation side, tariff pressure creates an incentive to optimize formulations for cost-effective raw material use and to redesign packaging to reduce import duty classifications where legally permissible. Over the medium term, policy-driven trade barriers can accelerate regional manufacturing investments and supplier diversification as companies seek to protect margin and maintain supply reliability for high-volume surgical settings. In sum, tariffs act as a catalyst for supply chain reconfiguration, procurement optimization, and selective onshoring where economic and regulatory conditions justify capital investment.

In-depth segmentation analysis that connects product formulation, composition science, clinical application, end-user requirements, and distribution channel economics to strategic priorities

Segment-level performance and product strategy are best understood through multiple analytical lenses that together reveal clinical fit, commercial potential, and operational requirements. Analysis by product type differentiates Cohesive, Combined, Dispersive, and Viscoadaptive formulations, where cohesive products typically prioritize chamber maintenance and facile removal, dispersive variants emphasize endothelial protection and retention during complex maneuvers, combined formulations seek to balance those attributes, and viscoadaptive solutions adapt properties under changing shear conditions. Composition-based segmentation highlights the role of Combination products, Hydroxypropyl Methylcellulose, and Sodium Hyaluronate in determining viscoelastic behavior, user preference, and raw material dependencies; sodium hyaluronate continues to be favored in many advanced formulations for its viscoelastic stability, while hydroxypropyl methylcellulose offers handling profiles valued in specific surgical workflows.

Application-based distinctions across Cataract Surgery, Corneal Surgery, Glaucoma Surgery, and Vitreoretinal Surgery illuminate divergent clinical requirements. Cataract procedures demand OVDs that enable predictable capsular support and lens placement, corneal interventions prioritize endothelial protection, glaucoma surgeries emphasize space maintenance for angle-based maneuvers, and vitreoretinal operations often require specialized handling during posterior segment access. End-user segmentation covering Ambulatory Surgery Centers, Hospitals, and Specialty Clinics underscores procurement and usage differences; ambulatory centers value products that support throughput and ease of use, hospitals often require a broader formulary to accommodate complex cases, and specialty clinics may demand niche formulations aligned to subspecialty procedures. Distribution channel analysis across Direct Sales, Distributor Partners, and Ecommerce reveals contrasting go-to-market models: direct sales can deliver tailored clinical support and contracting, distributor partners facilitate broad geographic reach and inventory management, and ecommerce channels provide convenience and data transparency but require robust logistics and regulatory compliance mechanisms. Combined, these segmentation perspectives inform product development priorities, clinical education programs, and commercial channel investments that align with specific procedural and customer needs.

A regionally nuanced perspective identifying distinct procurement behaviors, regulatory imperatives, and supply chain considerations across global territories

Regional dynamics shape product preferences, regulatory pathways, and supply chain design, producing differentiated competitive landscapes across major territories. In the Americas, established surgical volumes, mature procurement systems, and a strong presence of ambulatory surgery centers create demand for a wide range of OVD formulations that emphasize handling consistency and regulatory compliance. Manufacturers operating in these markets must balance rapid service expectations with stringent quality oversight, and they often prioritize clinical evidence generation and KOL engagement to support product adoption.

Europe, Middle East & Africa present a heterogeneous environment where divergent reimbursement frameworks, variable regulatory harmonization, and regional supply chain complexities necessitate localized market approaches. In some countries within this region, centralized procurement or hospital group purchasing drives price sensitivity, while in others, clinical preference and specialist networks exert stronger influence on adoption. Manufacturers benefit from adaptable regulatory strategies and targeted clinical programs to navigate this diversity. Asia-Pacific displays a combination of high-volume demand centers, rapid surgical capacity expansion, and growing domestic manufacturing capabilities. The region includes fast-growing ambulatory networks alongside large tertiary hospitals, and stakeholders often prioritize cost-effective formulations paired with robust supply continuity. Across all regions, cross-border regulatory alignment, export controls, and raw material sourcing considerations play pivotal roles in shaping manufacturing footprints and distribution strategies.

Strategic competitive analysis highlighting how innovation, supply continuity, and value-added services are redefining leadership and differentiation in the OVD sector

Competitive dynamics within the OVD space are characterized by a mix of legacy manufacturers, specialists, and emerging players employing differentiated go-to-market strategies. Leading firms are investing in formulation science to extend clinical utility while also refining packaging and delivery systems to improve handling and reduce waste. Strategic priorities include expanding direct clinical engagement, securing raw material supply chains for high-purity hyaluronate sources, and leveraging regulatory approvals to support label expansions in key therapeutic applications.

Smaller and mid-sized companies often focus on niche indications, cost-competitive formulations, or geographically targeted distribution partnerships to consolidate presence. Across tiers, companies are increasingly pursuing collaborative models that combine clinical training programs with bundled procurement offers for ambulatory centers and hospital systems. Mergers and acquisitions remain an active strategic lever, used to acquire proprietary formulations, expand manufacturing capacity, or access complementary distribution networks. Service differentiation through clinical education, post-market surveillance, and value-based contracting is becoming more central to competitive positioning as buyers expect not only product performance but also predictable supply and demonstrable outcomes support. Intellectual property management and quality system maturity continue to be critical determinants of competitive advantage, particularly for companies seeking to expand into regulated markets with rigorous approval requirements.

Actionable strategic roadmap recommending formulation investment, supply diversification, commercial model adaptation, and regulatory preparedness to sustain growth

Industry leaders should consider a multi-pronged approach that addresses clinical differentiation, supply resilience, commercial agility, and regulatory foresight. First, prioritize investment in formulation science that targets clear clinical advantages-whether through improved endothelial protection, ease of removal, or optimized viscoelastic behavior-to create defensible product differentiation that surgeons can readily adopt within standard workflows. Next, strengthen raw material sourcing through strategic agreements and diversified supplier bases to reduce exposure to trade disruptions and to improve negotiating leverage on cost and lead times.

Commercial models should be adapted to evolving procurement landscapes by expanding direct engagement with ambulatory surgery centers and large hospital systems, while refining distributor relationships to ensure geographic coverage and inventory responsiveness. Digital enablement across ordering, inventory visibility, and post-market feedback can enhance customer experience and provide actionable usage data. Regulatory and quality systems must be continuously upgraded to address emerging regional requirements and to accelerate label expansions; proactive engagement with regulatory authorities and investment in robust clinical evidence will facilitate market access. Finally, develop contingency plans for tariff and trade policy volatility that combine flexible inventory strategies, regional production options, and cost engineering to protect margins without compromising clinical performance. These recommendations together form an actionable roadmap to drive adoption, protect supply, and sustain competitive momentum.

A transparent and rigorous research approach combining expert interviews, regulatory review, clinical literature synthesis, and iterative triangulation to ensure actionable findings

The research underpinning this summary relied on a blend of structured primary interviews, targeted secondary analysis, and methodical triangulation to ensure robustness and relevance. Primary inputs were gathered through in-depth interviews with ophthalmic surgeons, procurement officers from ambulatory and hospital settings, regulatory experts, and senior commercial executives, all of whom provided contextual perspectives on clinical priorities, purchasing drivers, and supply chain challenges. Secondary inputs included publicly available regulatory documents, clinical literature, device registries, and corporate disclosures, which were synthesized to validate clinical claims, manufacturing practices, and distribution models.

Data and insight triangulation was applied to reconcile discrepancies between stakeholder perspectives and published information, with iterative validation cycles used to refine interpretations. The methodology incorporated careful attention to regional regulatory frameworks and to procedural trends that influence formulation selection and usage patterns. Where assumptions were required, they were explicitly tested through follow-up interviews and scenario analysis to assess sensitivity to policy shifts, procurement changes, and clinical adoption barriers. The overall approach emphasizes transparency in source provenance, disciplined cross-validation, and the integration of clinical and commercial viewpoints to produce actionable intelligence for decision-makers.

A concise synthesis emphasizing clinical drivers, supply resilience, and coordinated commercial strategies necessary to navigate evolving ophthalmic device dynamics

In closing, the OVD segment is marked by enduring clinical relevance, accelerating innovation, and a commercial landscape that is adapting to new surgical workflows and procurement realities. Clinical needs remain the primary driver: formulations that reliably protect ocular tissues, support advanced intraocular procedures, and integrate smoothly into high-throughput settings will command attention from clinicians and purchasing stakeholders alike. At the same time, supply chain resilience and regulatory agility have emerged as essential operational priorities, particularly in the context of trade policy shifts and fluctuating raw material access.

Stakeholders who align product development with clear procedural benefits, who invest in demonstrable clinical evidence, and who pursue flexible commercial models will be best positioned to capture long-term value. The interplay between formulation innovation, regional regulatory differences, and distribution model evolution underscores the need for coordinated strategies that span R&D, manufacturing, and customer engagement. By focusing on clinical differentiation, supply continuity, and responsive commercial execution, industry participants can navigate near-term disruptions while building durable competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of advanced cohesive dispersive OVDs for complex cataract surgeries improving patient outcomes
  • 5.2. Integration of drug-eluting ophthalmic viscosurgical devices for targeted postoperative therapy delivery
  • 5.3. Growing demand for prefilled single-use viscoelastic injectors reducing contamination risk and procedural time
  • 5.4. Expansion of micro-incision cataract surgery driving innovations in low-viscosity OVD formulations
  • 5.5. Development of bioresorbable viscoelastics enhancing corneal endothelial protection and faster recovery
  • 5.6. Strategic partnerships between device manufacturers and research institutes accelerating OVD technology advancements
  • 5.7. Regulatory approvals of novel viscoelastic polymers enabling safer and more effective intraocular procedures
  • 5.8. Increase in geriatric population fueling demand for specialized ophthalmic viscosurgical devices in emerging markets
  • 5.9. Emergence of tear film-mimicking viscoelastic combinations for improved lubricity during ophthalmic interventions
  • 5.10. Focus on cost-effective OVD solutions for high-volume surgical centers in resource-constrained regions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ophthalmic Viscosurgical Devices Market, by Product Type

  • 8.1. Cohesive
  • 8.2. Combined
  • 8.3. Dispersive
  • 8.4. Viscoadaptive

9. Ophthalmic Viscosurgical Devices Market, by Composition

  • 9.1. Combination
  • 9.2. Hydroxypropyl Methylcellulose
  • 9.3. Sodium Hyaluronate

10. Ophthalmic Viscosurgical Devices Market, by Application

  • 10.1. Cataract Surgery
  • 10.2. Corneal Surgery
  • 10.3. Glaucoma Surgery
  • 10.4. Vitreoretinal Surgery

11. Ophthalmic Viscosurgical Devices Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Ophthalmic Viscosurgical Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Partners
  • 12.3. Ecommerce

13. Ophthalmic Viscosurgical Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ophthalmic Viscosurgical Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ophthalmic Viscosurgical Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Alcon Laboratories, Inc.
    • 16.3.2. Johnson & Johnson
    • 16.3.3. Bausch + Lomb Incorporated
    • 16.3.4. Carl Zeiss Meditec AG
    • 16.3.5. HOYA Surgical Optics, Inc.
    • 16.3.6. Santen Pharmaceutical Co., Ltd.
    • 16.3.7. Rayner Group
    • 16.3.8. Nordic Pharma, Inc.
    • 16.3.9. Bohus BioTech AB
    • 16.3.10. BVI Medical, Inc. a

LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. OPHTHALMIC VISCOSURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VISCOADAPTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SODIUM HYALURONATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CORNEAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY VITREORETINAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTOR PARTNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 222. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 234. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 235. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. GCC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 253. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 258. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 259. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. BRICS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 270. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 271. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. G7 OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 277. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 282. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 283. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. NATO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMPOSITION, 2025-2032 (USD MILLION)
  • TABLE 295. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2